Search Browse Earnings

ACHIEVE LIFE SCIENCES, INC.

Nasdaq:ACHV

In Vitro & In Vivo Diagnostic Substances·SEATTLE, WA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

ACHIEVE LIFE SCIENCES, INC. — SlamSEC

Revenue

$0

FY 2019

Adj. EBITDA

—

Net Income

-$42.4M

FY 2024

EPS (Diluted)

-$4.00

FY 2024

Stock Price

$4.27

-3.0%

2026-03-06

52W Range

$1.84 – $6.03

P/E Ratio

-1.1x

Market Cap

$227.3M

Cash

$15.5M

FY 2024

Total Debt

—

Net Cash

$15.5M

FY 2019

Enterprise Value

$211.8M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—